483Feb 7, 2022

483 Document: Xellia Pharmaceuticals USA LLC

Lisa R. Hilliard, FDA Investigator Andrew J. Barrowcliff, FDA Investigator

FDANews 483 Xellia Pharmaceuticals USA LLC Feb 7 2022 top

Lisa R. Hilliard FDA Investigator Andrew J. Barrowcliff FDA Investigator

On Feb 07, 2022, the FDA inspected Xellia Pharmaceuticals USA LLC's Bedford site. Explore the inspectional observations.